New directions in antihistamine research
- 1 March 1997
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 7 (3), 201-207
- https://doi.org/10.1517/13543776.7.3.201
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- EbastineDrugs, 1996
- MizolastineDrugs of the Future, 1996
- Synthesis and Pharmacology of Combined Histamine H1‐/H2‐Receptor Antagonists Containing Diphenhydramine and Cyproheptadine DerivativesArchiv der Pharmazie, 1996
- Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea‐pigsClinical and Experimental Allergy, 1995
- Patent Update: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Platelet-activating factor receptor antagonistsExpert Opinion on Therapeutic Patents, 1995
- (Piperidinylalkoxy)chromones: Novel Antihistamines with Additional Antagonistic Activity against Leukotriene D4Journal of Medicinal Chemistry, 1995
- [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine Derivatives as Dual Antagonists of PAF and HistamineJournal of Medicinal Chemistry, 1994
- Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycinClinical Pharmacology & Therapeutics, 1992
- Cardiotoxic effects of astemizole overdose in childrenThe Journal of Pediatrics, 1992
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983